Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/23/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. BABA
7. AVGO
8. SPCX
9. NTES
10. DE

Go back to Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial
(AMEX: NMLSF) Delayed: 0.06 --0 (-0%)
Previous Close $0.06    52 Week High $ 
Open $0.06    52 Week Low $ 
Day High $0.06    P/E N/A 
Day Low $0.06    EPS $ 
Volume 37,727